Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient

Pilar Moreno1 email, Macarena Alvarez1 email, Lilia López1,2 email, Gonzalo Moratorio1 email, Didier Casane3 email, Matías Castells1 email, Silvia Castro4 email, Juan Cristina1 email and Rodney Colina1 email

Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay

Servicio Nacional de Sangre, Montevideo, Uruguay

Laboratoire Evolution Génomes Spéciation, CNRS 91198 Gif-sur-Yvette, France

Cátedra de hemoterapia, Hospital de Clínicas, Montevideo, Uruguay

author email corresponding author email

Virology Journal 2009, 6:203doi:10.1186/1743-422X-6-203

Published: 18 November 2009

Abstract

Background/Aim

Hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in patients affected by hereditary bleeding disorders. HCV, as others RNA virus, exploit all possible mechanisms of genetic variation to ensure their survival, such as recombination and mutation. In order to gain insight into the genetic variability of HCV virus strains circulating in hemophiliac patients, we have performed a phylogenetic analysis of HCV strains isolated from 10 patients with this kind of pathology.

Methods

Putative recombinant sequence was identified with the use of GARD program. Statistical support for the presence of a recombination event was done by the use of LARD program.

Results

A new intragenotypic recombinant strain (1b/1a) was detected in 1 out of the 10 hemophiliac patient studied. The recombination event was located at position 387 of the HCV genome (relative to strain AF009606, sub-type 1a) corresponding to the core gene region.

Conclusion

Although recombination may not appear to be common among natural populations of HCV it should be considered as a possible mechanism for generating genetic diversity in hemophiliacs patients.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.